Larvol Delta - Adcentrx-Therapeutics-Announces-FDA-Clearance-of-Investigational-New-Drug-Application-for-ADRX0405-a-Potential-FirstinClass-ADC-Targeting-STEAP1-for-the-Treatment-of-Advanced-Solid-Tumors

ADRX-0405 - Adcentrx Therap

https://www.prnewswire.com/news-releases/adcentrx-therapeutics-announces-fda-clearance-of-investigational-new-drug-application-for-adrx-0405-a-potential-first-in-class-adc-targeting-steap1-for-the-treatment-of-advanced-solid-tumors-302281352.html

Oct 21, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next